INVENT Ventures Announces 2013 Achievements of Portfolio Companies
May 06 2014 - 5:27AM
Access Wire
SANTA MONICA, CA / ACCESSWIRE / May 6, 2014 - INVENT Ventures
(OTCQB: IDEA) a venture firm that builds, manages, and invests
in early-stage web and mobile technology companies, today announced
its highlights for 2013 which include business accomplishments
from its portfolio of companies.
Operational and Portfolio Company Highlights from
2013
- INVENT Ventures reported a 36% year-over-year growth in
revenues for the full year of 2013. Total revenues generated
from its portfolio of companies increased from $105,987 to
$144,144
- Stockr, Inc. ("Stockr"), the world’s most advanced social
network for the investment community, won the prestigious Vator
Splash LA 2013 Startup competition that featured more than 100 of
the most promising startups in Los Angeles.
- Sanguine Biosciences, Inc. ("Sanguine"), a rapidly-growing
technology company in the personalized medicine and biomedical
research market, was selected as a Global Finalist for the
2013 StartmeupHK Venture Program in Hong Kong. Sanguine
was one of 12 finalists selected from 384 company entries from 39
countries and cities including the US, Israel, the UK, Canada,
India, Malaysia, Korea, Japan, Hong Kong and others.
- Sanguine signed Agreements with more than 200 Partners to enable
more efficient personalized medicine research.
- Sanguine announced an International Distribution
Partnership with AMS Biotechnology to make its products and
services available to researchers in Europe.
- Virurl, Inc. (“Virurl”), a top advertising technology
company rebranded its award-winning native advertising
platform as Revenue.com and launched new In-Stream Native Ad
product.
- Virurl was nominated as a finalist in the
Advertising category at the 3rd Annual Siemer Silicon
Beach Summit in Santa Monica, CA
"Our portfolio companies continue to establish themselves
as industry leaders," said Bryce Knight, CEO of INVENT Ventures. He
continued "2013 was a stellar year marked by tremendous market
acceptance, and we are excited by the accelerating momentum that we
are realizing in 2014."
About INVENT Ventures, Inc.
INVENT Ventures (OTCQB: IDEA) is a venture firm that builds,
manages, and invests in early-stage web and mobile technology
companies. INVENT is headquartered in Santa
Monica, California in the dynamic Silicon Beach area. For more
information on INVENT, visit www.invent.vc.
Safe Harbor Statement
Certain statements contained in this document that are not
historical fact are "forward-looking statements" as that term
is defined in the Private Securities Litigation Reform Act of
1995. The words or phrases "will likely result," "are expected
to," "will continue," "is anticipated," "believes,"
"estimates," "projects" or similar expressions are intended to
identify these forward-looking statements. These statements
are subject to risks and uncertainties beyond our reasonable
control that could cause our actual business and results of
operations to differ materially from those reflected in our
forward looking statements. The safe harbor provisions provided in
the Securities Litigation Reform Act do not apply to forward
looking statements we make in this document. Forward-looking
statements are not guarantees of future performance. We based
our forward-looking statements on our current expectations
about future events. Although we believe that the expectations
reflected in our forward-looking statements are reasonable,
we cannot guarantee you that these expectations actually will
be achieved. We are under no duty to update any of the
forward-looking statements after the date of this filing to
conform those statements to actual results. In evaluating
these statements, you should consider various factors,
including the Risk Factors.
Investor and Media Contact:
IRTH Communications
Robert Haag
866-976-4784
idea@irthcommunications.com
SOURCE: INVENT Ventures
Invent Ventures (PK) (USOTC:IDEA)
Historical Stock Chart
From Jan 2025 to Feb 2025
Invent Ventures (PK) (USOTC:IDEA)
Historical Stock Chart
From Feb 2024 to Feb 2025